What is the recommended dose of MiraLAX (polyethylene glycol) for a 4-year-old female patient with constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MiraLAX Dosing for a 4-Year-Old Female

For a 4-year-old child with constipation, start with polyethylene glycol (MiraLAX) at approximately 0.4-0.8 grams per kilogram per day (typically 8-12 grams daily for an average 4-year-old), mixed in 4-8 ounces of any beverage, given once daily. 1, 2

Initial Dosing Strategy

  • Start conservatively at the lower end of the dosing range (approximately 0.4-0.5 gm/kg/day) to minimize side effects while assessing response 2
  • For an average 4-year-old weighing 15-20 kg, this translates to approximately 8-10 grams daily as a starting dose 2
  • Mix the powder completely in any beverage (cold, hot, or room temperature) until fully dissolved before drinking 3
  • Do not give if clumps remain in the liquid 3

Dose Titration Approach

  • Titrate upward gradually if constipation persists, based on symptom response and side effects 1
  • Allow 24-48 hours or longer before increasing the dose, as improvement may be delayed 1
  • The average effective dose in pediatric studies was 0.63 gm/kg daily, with some children requiring up to 0.69 gm/kg 2
  • For persistent constipation, doses can be increased incrementally by 2-4 grams every few days until achieving the goal of one soft, non-forced bowel movement every 1-2 days 1

Treatment Goals and Monitoring

  • Target outcome: One soft, non-forced bowel movement every 1-2 days 1
  • Monitor for treatment response, which typically shows significant increase in bowel movement frequency within the first week 2
  • Ensure adequate hydration while using polyethylene glycol 1

Common Side Effects to Anticipate

  • Diarrhea is the most common adverse effect (occurred in 9 of 46 children in one study) 2
  • Abdominal distension, loose stool, flatulence, and nausea may occur 4
  • These side effects are generally dose-dependent and can be managed by reducing the dose temporarily 5

Important Clinical Caveats

FDA Labeling Limitation

  • The FDA-approved labeling states "children 16 years of age or under: ask a doctor," meaning MiraLAX is used off-label in pediatric patients under 17 years 3
  • However, extensive clinical research supports its safety and efficacy in children, making it a preferred option 2, 6

Adjunctive Measures

  • Always address underlying triggers: ensure adequate fluid intake, encourage physical activity, and optimize dietary fiber 1
  • Consider adding behavioral interventions and scheduled toilet sitting, though these are limited at age 4 1

Duration of Therapy

  • PEG has shown durable response over 6 months in adult studies, and pediatric data support safe long-term use 4, 7
  • Unlike stimulant laxatives, PEG is non-addictive and suitable for chronic maintenance therapy 2, 6

Practical Administration Tips

  • PEG 3350 is a tasteless powder that can be mixed with any beverage the child prefers, improving compliance 2, 6
  • Do not combine with starch-based thickeners used for swallowing difficulties 3
  • The powder must be fully dissolved before administration 3

When to Reassess

  • If constipation persists despite dose titration to 0.7-0.8 gm/kg/day, the child may have persistent constipation requiring further evaluation 2
  • Children with persistent constipation despite adequate PEG dosing had significantly higher post-void residuals and were less likely to improve, suggesting the need for additional interventions 2

References

Guideline

Polyethylene Glycol Dosing for Infant Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lactulose Dosing for Infant Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.